Interfering with leukocyte integrin activation--a novel concept in the development of anti-inflammatory drugs - PubMed

Review

Interfering with leukocyte integrin activation--a novel concept in the development of anti-inflammatory drugs

Tiina J Hilden et al. Ann Med. 2006.

Abstract

Inflammation is a crucial response against invading pathogens, in which immune cells, including neutrophils and T cells, are recruited into tissue from the bloodstream to help clear infection. However, a prevailing inflammatory response where the immune cells attack healthy tissue is associated with many diseases, including asthma, rheumatoid arthritis, atherosclerosis and multiple sclerosis. Integrins are key players in the recruitment of immune cells from the bloodstream into tissues, and are thus therapeutic targets for intervention with inflammatory responses. Thus far, mainly extracellularly acting therapeutics (monoclonal antibodies) have been developed against integrins, targeting ligand binding sites in these heterodimeric adhesion receptors. However, since these therapeutics nonselectively block all integrin functions, some side effects are expected and have been observed. Therefore, novel concepts need to be developed in the therapeutic targeting of integrins. Recently, major advances have been made in the understanding of integrin biology. Integrin structures have been solved by X-ray crystallography, revealing unexpected data about the activation mechanism of integrins in cells. Additionally, several intracellular factors in the integrin activation process have been identified, providing potential specific targets for therapeutic intervention. Here, we present key events and players in leukocyte integrin activation, and discuss potential new drug targets in the prevention of inflammatory disease.

Similar articles

• Targeting leukocyte integrins in human diseases.

  Yonekawa K, Harlan JM. Yonekawa K, et al. J Leukoc Biol. 2005 Feb;77(2):129-40. doi: 10.1189/jlb.0804460. Epub 2004 Nov 17. J Leukoc Biol. 2005. PMID: 15548573 Review.

• Right on the spot. Chemokine triggering of integrin-mediated arrest of rolling leukocytes.

  Laudanna C, Alon R. Laudanna C, et al. Thromb Haemost. 2006 Jan;95(1):5-11. Thromb Haemost. 2006. PMID: 16543955 Review.

• T cell integrin activation by chemokines in inflammation.

  Tanaka Y. Tanaka Y. Arch Immunol Ther Exp (Warsz). 2000;48(6):443-50. Arch Immunol Ther Exp (Warsz). 2000. PMID: 11197597 Review.

• Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease.

  Ulbrich H, Eriksson EE, Lindbom L. Ulbrich H, et al. Trends Pharmacol Sci. 2003 Dec;24(12):640-7. doi: 10.1016/j.tips.2003.10.004. Trends Pharmacol Sci. 2003. PMID: 14654305 Review.

• Targeting integrin structure and function in disease.

  Staunton DE, Lupher ML, Liddington R, Gallatin WM. Staunton DE, et al. Adv Immunol. 2006;91:111-57. doi: 10.1016/S0065-2776(06)91003-7. Adv Immunol. 2006. PMID: 16938539 Review.

Cited by

• In vivo labeling method using a genetic construct for nanoscale resolution microscopy.

  Schröder J, Benink H, Dyba M, Los GV. Schröder J, et al. Biophys J. 2009 Jan;96(1):L01-3. doi: 10.1016/j.bpj.2008.09.032. Biophys J. 2009. PMID: 19134467 Free PMC article.

• Focal adhesion kinase regulates pathogen-killing capability and life span of neutrophils via mediating both adhesion-dependent and -independent cellular signals.

  Kasorn A, Alcaide P, Jia Y, Subramanian KK, Sarraj B, Li Y, Loison F, Hattori H, Silberstein LE, Luscinskas WF, Luo HR. Kasorn A, et al. J Immunol. 2009 Jul 15;183(2):1032-43. doi: 10.4049/jimmunol.0802984. Epub 2009 Jun 26. J Immunol. 2009. PMID: 19561112 Free PMC article.

• Nitric oxide/cGMP pathway signaling actively down-regulates α4β1-integrin affinity: an unexpected mechanism for inducing cell de-adhesion.

  Chigaev A, Smagley Y, Sklar LA. Chigaev A, et al. BMC Immunol. 2011 May 17;12:28. doi: 10.1186/1471-2172-12-28. BMC Immunol. 2011. PMID: 21586157 Free PMC article.

• Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT.

  Zhou Y, Chakraborty S, Liu S. Zhou Y, et al. Theranostics. 2011 Jan 18;1:58-82. doi: 10.7150/thno/v01p0058. Theranostics. 2011. PMID: 21547153 Free PMC article.

• Role of beta7 integrins in intestinal lymphocyte homing and retention.

  Gorfu G, Rivera-Nieves J, Ley K. Gorfu G, et al. Curr Mol Med. 2009 Sep;9(7):836-50. doi: 10.2174/156652409789105525. Curr Mol Med. 2009. PMID: 19860663 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon